C-Peptide Sourcing Guide Purity Specs Manufacturing Certifications

For biotech procurement teams and cosmetic formulation specialists, sourcing high-purity C-Peptide is a critical step in ensuring assay reproducibility and product efficacy. This guide serves as a definitive resource for evaluating raw material specifications, manufacturing certifications, and quality control protocols. By focusing on purity specs exceeding 98% by HPLC, rigorous third-party testing, and compliance with ISO 9001 and GMP standards, this document addresses key buyer pain points such as batch-to-batch consistency and endotoxin control. Whether for diabetes research, immunoassay development, or cosmetic blending, understanding these parameters helps buyers avoid substandard lots that compromise experimental data and final product quality.

Core Molecular Specs & Product Technical Index

C-Peptide, a 31-amino-acid polypeptide, is a critical biomarker in diabetes research and a functional ingredient in advanced cosmetic formulations. For B2B buyers, the core value lies in its high purity and structural integrity, which directly impacts assay specificity and formulation stability. Our product is manufactured to meet the highest industry standards, with a focus on eliminating cross-reactivity and ensuring consistent performance across applications.

• Purity Grade: ≥98% by HPLC, with options for ≥99% for research-grade applications, ensuring minimal interference in immunoassays.
• Molecular Weight: 3020.3 Da, verified by Mass Spectrometry (MS) for accurate identification.
• Solubility: Fully soluble in water and phosphate-buffered saline (PBS) at 1 mg/mL, facilitating easy formulation in cosmetic serums and lab buffers.
• Storage Requirements: Lyophilized powder stable at -20°C for 24 months; reconstituted solutions stable at 2-8°C for 7 days, preventing degradation.
• Testing Standard: Compliant with USP and EP monographs, with additional testing for peptide content (≥80% by UV) and residual solvents (≤500 ppm).

According to a 2023 market analysis by Grand View Research, the global peptide synthesis market is projected to reach $50.6 billion by 2030, with high-purity C-Peptide demand growing at a CAGR of 8.5% driven by diabetes research and cosmetic anti-aging applications.

Manufacturing Flow & Strict Quality Control System

Our C-Peptide production begins with rigorous raw material screening, where all amino acids are verified for chirality and purity via HPLC. The peptide is synthesized using solid-phase peptide synthesis (SPPS) with Fmoc chemistry, ensuring high coupling efficiency. Multi-stage purification via preparative HPLC achieves the target purity, followed by a lyophilization process that preserves structural integrity. Each batch undergoes third-party testing for endotoxin levels (<1 EU/mg), bioburden, and heavy metals, with long-term stability tests conducted at accelerated conditions (40°C/75% RH for 6 months) to confirm shelf-life claims.

Main Certification Standards We Support

• ISO 9001:2015 – Quality management system for consistent production processes.
• GMP (Good Manufacturing Practice) – Compliance with FDA and EMA guidelines for pharmaceutical-grade raw materials.
• Certificate of Analysis (CoA) – Batch-specific data including HPLC purity, MS verification, and endotoxin results.
• MSDS (Material Safety Data Sheet) – Detailed handling and storage instructions for safe laboratory use.

Main Commercial Application Scenarios

High-purity C-Peptide is a versatile raw material used across multiple industries, from cosmetic blending to advanced laboratory research. Its ability to minimize cross-reactivity and maintain stability makes it indispensable for both commercial and clinical workflows.

• Cosmetic Blending: Used in anti-aging serums and creams at concentrations of 0.1-1% to support skin firmness and hydration, with compatibility verified in oil-in-water emulsions.
• Laboratory Research: Essential for diabetes research, including ELISA and RIA assay development, where purity ≥98% ensures accurate biomarker quantification.
• Compound Raw Material Wholesale: Supplied in bulk quantities (1g to 1kg) for pharmaceutical intermediates and diagnostic kit manufacturing, with custom packaging options.

Comparison: C-Peptide VS Ordinary Low-Grade Peptide Raw Materials

Standard Buyer Selection Guide For Bulk Purchase

When sourcing C-Peptide for bulk procurement, common pitfalls include accepting low-purity lots that compromise assay results or formulations. To mitigate supply chain risks, buyers should prioritize suppliers with transparent manufacturing processes and verifiable certifications. Core screening criteria include purity specs, endotoxin control, and batch documentation. Always request a sample for in-house testing before committing to large orders, and verify supplier qualifications through third-party audits.

Key Inspection Checklist Before Cooperation

• Purity Verification: Request HPLC chromatogram and MS data for each batch.
• Endotoxin Testing: Confirm levels are <1 EU/mg for research-grade material.
• Certification Validity: Check ISO 9001 and GMP certificates are current and audited.
• Stability Data: Review accelerated stability studies for long-term storage.
• Packaging Integrity: Ensure lyophilized powder is sealed under inert gas to prevent moisture absorption.

Core Competitive Advantages Of Our C-Peptide

Our C-Peptide stands out due to its exceptional purity (≥98% by HPLC) and rigorous quality control, which ensures batch-to-batch consistency with a coefficient of variation (CV) below 3%. This stability is critical for clinical and diagnostic workflows where data reproducibility is paramount. Additionally, our competitive pricing model offers cost savings of up to 20% compared to premium suppliers, without compromising on technical support. We provide free consultation on formulation integration and assay optimization, helping buyers streamline their vendor qualification process.

Frequently Asked Questions

Q: What is the minimum purity required for C-Peptide in immunoassay development?

A: For immunoassay development, a minimum purity of 98% by HPLC is recommended to minimize cross-reactivity with proinsulin and insulin. Lower purity grades (e.g., 85-90%) can lead to false positives and compromised assay specificity, making high-purity C-Peptide essential for accurate biomarker quantification.

Q: How does endotoxin control impact the use of C-Peptide in cell-based research?

A: Endotoxin levels below 1 EU/mg are critical for cell-based research, as higher levels can induce inflammatory responses and skew experimental results. Our C-Peptide is tested to ensure endotoxin compliance, making it suitable for sensitive applications like primary cell cultures and in vivo studies.

Q: What documentation should I request to verify C-Peptide batch quality?

A: Request a Certificate of Analysis (CoA) that includes HPLC purity percentage, mass spectrometry (MS) verification, endotoxin levels, and residual solvent analysis. Additionally, ask for stability data under recommended storage conditions to confirm shelf-life claims and batch-to-batch consistency.